Surgical treatment of end-stage heart failure such as a heart transplant or implantation of mechanical circulatory support (MCS) is mainly performed in patients with severely impaired systolic ventricular function due to end-stage cardiomyopathies who remain symptomatic despite optimal guideline-recommended treatment [8]. International guidelines recommend a heart transplant in end-stage heart failure and in the absence of contraindications (Table 1) [9, 10]. A consensus statement of the International Society of Heart and Lung Transplantation regulates listing and management policies for potential cardiac transplant candidates and was last updated in 2016 [11].